Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 215-218

  Yang, Wei ^a   Paschen, Wulf ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell division; Gene expression; Microarray; miRNA; SUMO2 3

Indexed keywords

MICRORNA; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TARGETING;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE SILENCING; RATS; RNA, SMALL INTERFERING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 63149104639     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.013     Document Type: Article

References (15)

1. Matunis M.J., Coutavas E., and Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135 (1996) 1457-1470
2. Manza L.L., Codreanu S.G., Stamer S.L., Smith D.L., Wells K.S., Roberts R.L., and Liebler D.C. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17 (2004) 1706-1715
3. Anckar J., Hietakangas V., Denessiouk K., Thiele D.J., Johnson M.S., and Sistonen L. Inhibition of DNA binding by differential sumoylation of heat shock factors. Mol. Cell. Biol. 26 (2006) 955-964
4. Lee Y.J., Miyake S., Wakita H., McMullen D.C., Azuma Y., Auh S., and Hallenbeck J.M. Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J. Cereb. Blood Flow Metabol. 27 (2007) 950-962
5. Cimarosti H., Lindberg C., Bomholt S.F., Ronn L.C., and Henley J.M. Increased protein SUMOylation following focal cerebral ischemia. Neuropharmacology 54 (2008) 280-289
6. Yang W., Sheng H., Warner D.S., and Paschen W. Transient global cerebral ischemia induces a massive increase in protein sumoylation. J. Cereb. Blood Flow Metabol. 28 (2008) 269-279
7. Yang W., Sheng H., Warner D.S., and Paschen W. Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation. J. Cereb. Blood Flow Metabol. 28 (2008) 892-896
8. Yang W., Sheng H., Homi H.M., Warner D.S., and Paschen W. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation - a new target for therapeutic intervention?. J. Neurochem. 106 (2008) 989-999
9. Wilson V.G., and Heaton P.R. Ubiquitin proteolytic system: focus on SUMO. Expert Rev. Proteomics 5 (2008) 121-135
10. Otey C.A., Boukhelifa M., and Maness P. B35 neuroblastoma cells: an easily transfected, cultured cell model of central nervous system neurons. Methods Cell Biol. 71 (2003) 287-304
11. Hayashi T., Seki M., Maeda D., Wang W., Kawabe Y., Seki T., Saitoh H., Fukagawa T., Yagi H., and Enomoto T. Ubc9 is essential for viability of higher eukaryotic cells. Exp. Cell Res. 280 (2002) 212-221
12. Zhang F.P., Mikkonen L., Toppari J., Palvimo J.J., Thesleff I., and Janne O.A. SUMO-1 function is dispensable in normal mouse development. Mol. Cell. Biol. 28 (2008) 5381-5390
13. Zhang X.D., Goeres J., Zhang H., Yen T.J., Porter A.C., and Matunis M.J. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29 (2008) 729-741
14. Azuma Y., Arnaoutov A., and Dasso M. SUMO-2/3 regulates topoisomerase II in mitosis. J. Cell Biol. 163 (2003) 477-487
15. Liu G., and Warbrick E. The p66 and p12 subunits of the DNA polymerase δ are modified by ubiquitin and ubiquitin-like proteins. Biochem. Biophys. Res. Commun. 349 (2006) 360-366